Tag Archives: PEPFAR treatment targets

More complete data on PEPFAR results needed, says second GAO treatment report

By on .

The second of two reports from the U.S. Government Accountability Office reviewing HIV treatment efforts suppported by the President’s Emergency Plan For AIDS Relief concludes that incomplete information on the results of those efforts will interfere with accurately evaluating partner countries’ abilities to sustain treatment programs. The GAO also has produced a report on PEPFAR […]

Blueprint: Dr. Myron Cohen on treatment as prevention and other essential elements of a global AIDS plan

By on .

Dr. Myron S. Cohen is the architect and principal investigator of the multinational HPTN 052 trial, which demonstrated that antiretroviral treatment prevents the sexual transmission of HIV-1. This work was recognized by Science Magazine as the “Breakthrough of the Year” in 2011. His research focuses on the transmission and prevention of transmission of HIV, and […]

PEPFAR advisory board applies implementation science, ethics to efforts

By on .

In the life of the President’s Emergency Plan For AIDS Relief so far, the concept of exploring its efficiency, its impact, the relevance of it targets even, is relatively young. When all of those are weighed against intentions and costs, the discipline at work is called “implementation science,” and that is the science, PEPFAR leadership […]

HIV/AIDS Physician-Scientists, Advocates Call for Bold HIV Treatment Goals for PEPFAR

By on .

Physician-scientists working on the frontlines of the HIV/AIDS epidemic today urged the White House to set bold new HIV treatment targets for PEPFAR, the U.S. President’s Emergency Plan for AIDS Relief. The Center for Global Health Policy joined with a coalition of other organizations—including HealthGAP, amfAR (the Foundation for AIDS Research), the Treatment Action Group, […]